Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Libraries
  3. MIT Theses
  4. Graduate Theses
  5. Raw Material Optimization to Bend the Biopharmaceutical Cost Curve

Raw Material Optimization to Bend the Biopharmaceutical Cost Curve

Thumbnail Image
Download
Name

chen-julchen-mba-sloan-2021-thesis.pdf

Description
Thesis PDF
Size

6.04 MB

Format

Adobe PDF

Checksum (MD5)

ef25d3637e7fe27f44313e14d46c74ed

Author(s)
Chen, Julia Mengpei
Advisor(s)
Zheng, Yanchong
Simchi-Levi, David
Date Issued
June 2021
Publisher
Massachusetts Institute of Technology
Abstract
Raw materials sourced from sole third-party suppliers have been identified as one of the key risks to Amgen’s operation. This project aims to reduce raw material costs through sourcing alternative materials and optimizing material consumption. To systematically evaluate alternative material supply, a cross-functional assessment framework consolidating qualitative and quantitative inputs with flexibility option analysis for uncertainties is established. Case studies are conducted on a chromatography resin and a cell culture media constituent, both of which are currently sourced from single channel. To optimize raw material consumption, an integrated biomanufacturing process and material cost model is developed to provide recommendations on the process parameters and the use of raw materials. The optimization model incorporates equipment capacity constraints as well as material consumption across all stages of drug substance manufacturing. The model is applied to the development of a next-generation process for a commercial molecule and identifies process operating conditions where the raw material costs can be reduced while maximizing productivity. Sensitivity analyses are conducted to understand the impact of uncertainties to materials costs and process yields. Material cost sensitivity analysis reveals the importance of material order planning and alternative material opportunities. Overall, the project adopts a systematic approach to reduce costs and mitigate raw material risks at an early stage of the biopharmaceutical product life cycle.
MIT Department
Sloan School of Management
Massachusetts Institute of Technology. Department of Civil and Environmental Engineering
Terms of Use
In Copyright - Educational Use Permitted
https://rightsstatements.org/page/InC-EDU/1.0/
Copyright retained by author(s)
Persistent DSpace Link
https://hdl.handle.net/1721.1/139545
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.